Laos vs Samoa: New cases tested for RR-/MDR-TB

Laos
100.0%
in 2024
Samoa
100.0%
in 2024
Laos rank
1st
Samoa rank
1st

New cases tested for RR-/MDR-TB over time

  • Laos
  • Samoa
020406080100201020172024

How they compare

Laos currently reports 100.0% against 100.0% in Samoa, a difference of 0.0%.

The two have swapped places 4 times across 11 shared years of data; in 2012 it was Samoa ahead.

Laos ranks 1st and Samoa ranks 1st of 192 countries.

Across the 2 decades both report, Laos averaged higher in 1 and Samoa in 1.

Head to head by decade

Decade Laos Samoa Difference Ahead
2010s 43.2% 83.4% 40.2% Samoa
2020s 97.2% 75.0% 22.2% Laos

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Laos or Samoa?
Laos, at 100.0% against 100.0% in Samoa as of 2024.
What is the difference in new cases tested for rr-/mdr-tb between Laos and Samoa?
0.0%, with Laos ahead.
How many years of comparable data are there for Laos and Samoa?
11 years are reported by both, from 2012 to 2024.
How do Laos and Samoa rank globally for new cases tested for rr-/mdr-tb?
Laos ranks 1st and Samoa ranks 1st of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Laos vs Samoa: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 28 August 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/lao-pdr/samoa/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/lao-pdr/samoa/">Laos vs Samoa: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
204 places, 3,368 data points, 2005–2024
Last refreshed